Stockreport

Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference

Septerna, Inc.  (SEPN) 
PDF SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein- [Read more]